drugset / Trial / NCT00238056

Effect of Domperidone on QT Interval in Premature Infants

NCT00238056

Phase 2 Completed Nantes University Hospital
Non-randomizedParallel-groupOpen-labelTreatment

Summary

30 premature infants treated by domperidone upon decision of the attending neonatologist will have a daily recording of electrocardiogram for the first 7 seven days of treatment, and pharmacokinetics dosages at Day 7. Their ECG will be compared to 30 non treated premature infants, matched for gestational age, postnatal age and sex.

Timeline

Start
Primary completion
Completion

Drugs

EvaluationDrugModalityDoseRoute
Subject Domperidone Unknown

Indications